Pautan luaran Akne

Klasifikasi
Sumber luar
  1. 1 2 3 4 5 6 7 8 9 10 11 12 "Emerging drugs for the treatment of acne". Expert Opinion on Emerging Drugs (Review). 20 (1): 91–101. March 2015. doi:10.1517/14728214.2015.990373. PMID 25474485.(langganan diperlukan)
  2. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 "Selected Disorders of Skin Appendages--Acne, Alopecia, Hyperhidrosis". The Medical Clinics of North America (Review). 99 (6): 1195–211. November 2015. doi:10.1016/j.mcna.2015.07.003. PMID 26476248.
  3. 1 2 3 4 5 6 7 8 "Epidemiology of acne vulgaris". The British Journal of Dermatology (Review). 168 (3): 474–85. March 2013. doi:10.1111/bjd.12149. PMID 23210645.
  4. ↑ "Acne vulgaris". Nature Reviews. Disease Primers. 1: 15033. September 2015. doi:10.1038/nrdp.2015.33. PMID 27227877.
  5. 1 2 "Frequently Asked Questions: Acne" (PDF). U.S. Department of Health and Human Services, Office of Public Health and Science, Office on Women's Health. July 2009. Diarkib daripada yang asal (PDF) pada 10 December 2016. Dicapai pada 30 July 2009.
  6. 1 2 "Quality of life measures for acne patients". Dermatologic Clinics (Review). 30 (2): 293–300, ix. April 2012. doi:10.1016/j.det.2011.11.001. PMID 22284143.
  7. 1 2 3 "Acne and acne scarring - the case for active and early intervention". Australian Family Physician (Review). 35 (7): 503–4. July 2006. PMID 16820822. Diarkib daripada yang asal pada 21 April 2013.
  8. 1 2 "Acne vulgaris: pathogenesis, treatment, and needs assessment". Dermatologic Clinics (Review). 30 (1): 99–106, viii–ix. January 2012. doi:10.1016/j.det.2011.09.001. PMID 22117871.
  9. 1 2 "Acne vulgaris in children and adolescents". Minerva Pediatrica (Review). 63 (4): 293–304. August 2011. PMID 21909065.
  10. ↑ "Clinical practice. Acne". The New England Journal of Medicine (Review). 352 (14): 1463–72. April 2005. doi:10.1056/NEJMcp033487. PMID 15814882.
  11. 1 2 3 4 5 6 7 8 9 10 11 12 13 "Acne Vulgaris". The New England Journal of Medicine (Review). 379 (14): 1343–1352. October 2018. doi:10.1056/NEJMcp1702493. PMID 30281982.
  12. 1 2 "[Diet and acne update: carbohydrates emerge as the main culprit]". Journal of Drugs in Dermatology (Review). 13 (4): 428–35. April 2014. PMID 24719062.
  13. 1 2 3 4 5 6 7 Titus S, Hodge J (October 2012). "Diagnosis and treatment of acne". American Family Physician (Review). 86 (8): 734–40. PMID 23062156. Diarkib daripada yang asal pada 18 February 2015.
  14. 1 2 "Propionibacterium acnes: an update on its role in the pathogenesis of acne". Journal of the European Academy of Dermatology and Venereology (Review). 28 (3): 271–8. March 2014. doi:10.1111/jdv.12224. PMID 23905540.
  15. 1 2 "Efficacy and adverse events of oral isotretinoin for acne: a systematic review". The British Journal of Dermatology. 178 (1): 76–85. January 2018. doi:10.1111/bjd.15668. PMID 28542914.
  16. ↑ GBD 2015 Disease Injury Incidence Prevalence Collaborators (October 2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.
  17. ↑ "The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions". The Journal of Investigative Dermatology. 134 (6): 1527–1534. June 2014. doi:10.1038/jid.2013.446. PMID 24166134.Selenggaraan CS1: display-pengarang (link)
  18. 1 2 3 "Pathways to inflammation: acne pathophysiology". European Journal of Dermatology (Review). 21 (3): 323–33. May–June 2011. doi:10.1684/ejd.2011.1357. PMID 21609898.
  19. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 "Acne vulgaris". BMJ (Review). 346 (5): 30–33. May 2013. doi:10.1136/bmj.f2634. JSTOR 23494950. PMID 23657180.
  20. 1 2 Goldberg DJ, Berlin AL (October 2011). Acne and Rosacea: Epidemiology, Diagnosis and Treatment. London: Manson Pub. m/s. 8. ISBN 978-1-84076-150-4. Diarkib daripada yang asal pada 2 July 2016.
  21. 1 2 "Diet and acne: a review of the evidence". International Journal of Dermatology (Review). 48 (4): 339–47. April 2009. doi:10.1111/j.1365-4632.2009.04002.x. PMID 19335417.
  22. 1 2 "Evaluation and treatment of acne from infancy to preadolescence". Dermatologic Therapy (Review). 26 (6): 462–6. November 2013. doi:10.1111/dth.12108. PMID 24552409.
  23. ↑ "acne", "vulgar". Oxford English Dictionary (ed. 2nd). Oxford: Oxford University Press. 2009.
  24. 1 2 Zaenglein AL, Graber EM, Thiboutot DM (2012). "Chapter 80 Acne Vulgaris and Acneiform Eruptions". Dalam Goldsmith, Lowell A., Katz, Stephen I., Gilchrest, Barbara A., Paller, Amy S., Lefell, David J., Wolff, Klaus (para penyunting). Fitzpatrick's Dermatology in General Medicine (ed. 8th). New York: McGraw-Hill. halaman 897–917. ISBN 978-0-07-171755-7.
  25. ↑ "Hidradenitis suppurrativa (acne inversa) as a systemic disease". Clinics in Dermatology (Review). 32 (3): 397–408. May–June 2014. doi:10.1016/j.clindermatol.2013.11.006. PMID 24767187.
  26. ↑ "Rosacea: new and emerging treatments". Drugs (Review). 74 (13): 1457–65. September 2014. doi:10.1007/s40265-014-0281-x. PMID 25154627.
  27. 1 2 3 "Acneiform eruptions". Clinics in Dermatology (Review). 32 (1): 24–34. January–February 2014. doi:10.1016/j.clindermatol.2013.05.023. PMID 24314375.
  28. ↑ "Scoring systems in acne vulgaris" (PDF). Indian Journal of Dermatology, Venereology and Leprology (Review). 75 (3): 323–6. May 2009. doi:10.4103/0378-6323.51258. PMID 19439902.
  29. 1 2 "A meta-analysis of association between acne vulgaris and Demodex infestation". Journal of Zhejiang University Science B (Meta-analysis). 13 (3): 192–202. March 2012. doi:10.1631/jzus.B1100285. PMC 3296070. PMID 22374611.
  30. 1 2 3 4 "Evaluation of Acne Scars: How to Assess Them and What to Tell the Patient". Dermatologic Clinics (Review). 34 (2): 207–13. April 2016. doi:10.1016/j.det.2015.11.009. PMID 27015781.
  31. 1 2 3 4 5 "Management of acne scarring, part II: a comparative review of non-laser-based, minimally invasive approaches". American Journal of Clinical Dermatology (Review). 13 (5): 331–40. October 2012. doi:10.2165/11631410-000000000-00000. PMID 22849351.
  32. 1 2 "Management of acne scars: fulfilling our duty of care for patients". The British Journal of Dermatology (Review). 172 Suppl 1 (Supplement 1): 47–51. July 2015. doi:10.1111/bjd.13650. PMID 25597636.
  33. ↑ "Management of acne scarring, part I: a comparative review of laser surgical approaches". American Journal of Clinical Dermatology (Review). 13 (5): 319–30. October 2012. doi:10.2165/11598910-000000000-00000. PMID 22612738.
  34. 1 2 3 Chandra M, Levitt J, Pensabene CA (May 2012). "Hydroquinone therapy for post-inflammatory hyperpigmentation secondary to acne: not just prescribable by dermatologists". Acta Dermato-Venereologica (Review). 92 (3): 232–5. doi:10.2340/00015555-1225. PMID 22002814.
  35. 1 2 3 4 5 "Acne in patients with skin of color: practical management". American Journal of Clinical Dermatology (Review). 15 (1): 7–16. February 2014. doi:10.1007/s40257-013-0049-1. PMID 24190453.
  36. ↑ "Postinflammatory hyperpigmentation: etiologic and therapeutic considerations". American Journal of Clinical Dermatology (Review). 12 (2): 87–99. April 2011. doi:10.2165/11536930-000000000-00000. PMID 21348540.
  37. ↑ Rigopoulos E, Korfitis C (2014). "Acne and Smoking". Dalam Zouboulis C, Katsambas A, Kligman AM (para penyunting). Pathogenesis and Treatment of Acne and Rosacea. Berlin: Springer-Verlag. halaman 167–170. ISBN 978-3-540-69374-1.
  38. ↑ Acne: Overview. PubMed Health. Cologne: Institute for Quality and Efficiency in Health Care. July 2016. Diarkib daripada yang asal pada 6 September 2017. Dicapai pada 12 March 2017. It is not clear whether there might be a connection between smoking and acne.
  39. ↑ "TNF-308 G/A polymorphism and risk of acne vulgaris: a meta-analysis". PLOS ONE (Systematic Review & Meta-Analysis). 9 (2): e87806. February 2014. Bibcode:2014PLoSO...987806Y. doi:10.1371/journal.pone.0087806. PMC 3912133. PMID 24498378.
  40. 1 2 Fitzpatrick TB (2005). Fitzpatrick's Color Atlas and Synopsis of Clinical Dermatology (ed. 5th). New York: McGraw-Hill Medical Pub. Division. m/s. 2. ISBN 978-0071440196.
  41. ↑ Hoeger PH, Irvine AD, Yan AC (2011). "Chapter 79: Acne". Harper's Textbook of Pediatric Dermatology (ed. 3rd). New Jersey: Wiley-Blackwell. ISBN 978-1-4443-4536-0.
  42. ↑ Shalita AR, Del Rosso JQ, Webster G, para penyunting (March 2011). Acne Vulgaris. CRC Press. halaman 33–. ISBN 978-1-61631-009-7. Diarkib daripada yang asal pada 9 December 2016.
  43. ↑ Zouboulis CC, Katsambas AD, Kligman AM, para penyunting (July 2014). Pathogenesis and Treatment of Acne and Rosacea. Springer. halaman 121–122. ISBN 978-3-540-69375-8. Diarkib daripada yang asal pada 10 December 2016.
  44. 1 2 3 4 5 6 7 "Recent advances in acne pathogenesis: implications for therapy". American Journal of Clinical Dermatology (Review). 15 (6): 479–88. December 2014. doi:10.1007/s40257-014-0099-z. PMID 25388823.
  45. ↑ "Polycystic ovary syndrome: a review for dermatologists: Part I. Diagnosis and manifestations". Journal of the American Academy of Dermatology (Review). 71 (5): 847.e1–847.e10, quiz 857–8. November 2014. doi:10.1016/j.jaad.2014.05.007. PMID 25437977.
  46. 1 2 3 4 5 6 7 8 9 "Treatment of acne vulgaris during pregnancy and lactation". Drugs (Review). 73 (8): 779–87. June 2013. doi:10.1007/s40265-013-0060-0. PMID 23657872.
  47. ↑ "Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem". Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology (Review). 5 (2): 110–7. February 2007. doi:10.1111/j.1610-0387.2007.06176.x. PMID 17274777.
  48. ↑ "Synthetic androgens as designer supplements". Current Neuropharmacology (Review). 13 (1): 89–100. January 2015. doi:10.2174/1570159X13666141210224756. PMC 4462045. PMID 26074745.
  49. 1 2 3 "Immunotherapy for acne vulgaris: current status and future directions". American Journal of Clinical Dermatology (Review). 14 (6): 429–35. December 2013. doi:10.1007/s40257-013-0042-8. PMID 24019180.
  50. 1 2 3 "What's new in acne? An analysis of systematic reviews published in 2011-2012". Clinical and Experimental Dermatology (Review). 39 (3): 273–7, quiz 277–8. April 2014. doi:10.1111/ced.12270. PMID 24635060.
  51. 1 2 3 Bronsnick T, Murzaku EC, Rao BK (December 2014). "Diet in dermatology: Part I. Atopic dermatitis, acne, and nonmelanoma skin cancer". Journal of the American Academy of Dermatology (Review). 71 (6): 1039.e1–1039.e12. doi:10.1016/j.jaad.2014.06.015. PMID 25454036.
  52. ↑ "Acne: risk indicator for increased body mass index and insulin resistance". Acta Dermato-Venereologica (Review). 93 (6): 644–9. November 2013. doi:10.2340/00015555-1677. PMID 23975508.
  53. ↑ "The role of diet in acne: facts and controversies". Clinics in Dermatology (Review). 28 (1): 12–6. January 2010. doi:10.1016/j.clindermatol.2009.03.010. PMID 20082944.
  54. ↑ "Does diet really affect acne?". Skin Therapy Letter (Review). 15 (3): 1–2, 5. March 2010. PMID 20361171. Diarkib daripada yang asal pada 21 February 2015.
  55. ↑ Melnik BC (2011). "Evidence for Acne-Promoting Effects of Milk and Other Insulinotropic Dairy Products". Milk and Milk Products in Human Nutrition. Nestle Nutrition Workshop Series. Paediatric Programme. Nestlé Nutrition Institute Workshop Series: Pediatric Program. 67. halaman 131–45. doi:10.1159/000325580. ISBN 978-3-8055-9587-2. PMID 21335995.
  56. ↑ "A review of vitamin B12 in dermatology". American Journal of Clinical Dermatology (Review). 16 (1): 27–33. February 2015. doi:10.1007/s40257-014-0107-3. PMID 25559140.
  57. ↑ "Acne". WebMD (dalam bahasa Inggeris). Diarkib daripada yang asal pada 24 January 2018. Dicapai pada 2018-01-24.
  58. ↑ Leach, Oliver; van Boxel, Gijsbert Isaac (2013). Crash Course General Medicine – E-Book (dalam bahasa Inggeris). Elsevier Health Sciences. m/s. 362. ISBN 9780723437895.
  59. ↑ "Psychologic factors in the development of facial dermatoses". Clinics in Dermatology (Review). 32 (6): 763–6. November–December 2014. doi:10.1016/j.clindermatol.2014.02.015. PMID 25441469.
  60. 1 2 "Dermatological manifestations of stress in normal and psychiatric populations". The Psychiatric Clinics of North America (Review). 37 (4): 625–51. December 2014. doi:10.1016/j.psc.2014.08.009. PMID 25455069.
  61. ↑ "Questions and Answers about Acne". National Institute of Arthritis and Musculoskeletal and Skin Diseases. May 2013. Diarkib daripada yang asal pada 2 February 2015.
  62. ↑ "Acne and its management". Pediatrics in Review (Review). 34 (11): 479–97. November 2013. doi:10.1542/pir.34-11-479. PMID 24187141.
  63. ↑ "Antibiotic resistance: shifting the paradigm in topical acne treatment". Journal of Drugs in Dermatology (Review). 13 (11): 1358–64. November 2014. PMID 25607703.
  64. 1 2 "Treatment of acne with tea tree oil (melaleuca) products: a review of efficacy, tolerability and potential modes of action". International Journal of Antimicrobial Agents (Review). 45 (2): 106–10. February 2015. doi:10.1016/j.ijantimicag.2014.10.011. PMID 25465857.
  65. 1 2 "Azelaic acid: Properties and mode of action". Skin Pharmacology and Physiology (Review). 27 Suppl 1 (Supplement 1): 9–17. November 2013. doi:10.1159/000354888. PMID 24280644.
  66. ↑ Simpson, Nicholas B.; Cunliffe, William J. (2004). "Disorders of the sebaceous glands". Dalam Burns, Tony; Breathnach, Stephen; Cox, Neil; Griffiths, Christopher (para penyunting). Rook's textbook of dermatology (ed. 7th). Malden, Mass.: Blackwell Science. halaman 431–75. ISBN 978-0-632-06429-8.
  67. ↑ "Staphylococcus epidermidis: A potential new player in the physiopathology of acne?". Dermatology (Review). 235 (4): 287–94. May 2019. doi:10.1159/000499858.
  68. ↑ "Evaluation of essential clinical components and features of current acne global grading scales". Journal of the American Academy of Dermatology (Review). 69 (5): 754–761. November 2013. doi:10.1016/j.jaad.2013.07.029. PMID 23972509.
  69. ↑ "Skin lesion metrics: role of photography in acne". The Journal of Dermatological Treatment (Review). 25 (2): 100–5. April 2014. doi:10.3109/09546634.2013.813010. PMID 23758271.
  70. ↑ "The Leeds Revised Acne Grading System" (PDF). The Leeds Teaching Hospitals. Diarkib daripada yang asal (PDF) pada 25 November 2015. Dicapai pada 23 November 2015.
  71. ↑ "Acne vulgaris". BMJ Clinical Evidence (Review). 2008: 1714. May 2008. PMC 2907987. PMID 19450306.
  72. ↑ "When Acne is Not Acne". Dermatologic Clinics (Review). 34 (2): 225–8. April 2016. doi:10.1016/j.det.2015.12.002. PMID 27015783.
  73. ↑ "Guidance on the diagnosis and clinical management of acne". Clinical and Experimental Dermatology (Review). 37 Suppl 1 (Supplement 1): 1–6. May 2012. doi:10.1111/j.1365-2230.2012.04335.x. PMID 22486762.
  74. ↑ Kanerva L, Elsner P, Wahlberg JH, Maibach HI, para penyunting (2013). Handbook of Occupational Dermatology (dalam bahasa Inggeris). Springer Science & Business Media. m/s. 231. ISBN 978-3-662-07677-4. Diarkib daripada yang asal pada 6 September 2017.
  75. 1 2 "Acne vulgaris: review and guidelines". Dermatology Nursing (Review). 21 (2): 63–8, quiz 69. March 2009. PMID 19507372.
  76. 1 2 "Newer approaches to the treatment of acne vulgaris". American Journal of Clinical Dermatology (Review). 13 (6): 357–64. December 2012. doi:10.2165/11632500-000000000-00000. PMID 22920095.
  77. 1 2 3 4 5 "Guidelines of care for the management of acne vulgaris". Journal of the American Academy of Dermatology (Review). 74 (5): 945–73.e33. May 2016. doi:10.1016/j.jaad.2015.12.037. PMID 26897386.Selenggaraan CS1: display-pengarang (link)
  78. ↑ "Blue-Light Therapy for Acne Vulgaris: A Systematic Review and Meta-Analysis". Annals of Family Medicine (Systematic Review & Meta-Analysis). 17 (6): 545–553. November 2019. doi:10.1370/afm.2445. PMC 6846280. PMID 31712293.Selenggaraan CS1: display-pengarang (link)
  79. ↑ "Topical acne treatments in Europe and the issue of antimicrobial resistance". Journal of the European Academy of Dermatology and Venereology (Review). 29 (8): 1485–92. August 2015. doi:10.1111/jdv.12989. PMID 25677763.
  80. 1 2 3 Gamble R, Dunn J, Dawson A, Petersen B, McLaughlin L, Small A, dll. (June 2012). "Topical antimicrobial treatment of acne vulgaris: an evidence-based review". American Journal of Clinical Dermatology (Review). 13 (3): 141–52. doi:10.2165/11597880-000000000-00000. PMID 22268388. Parameter |s2cid= yang tidak diketahui diendahkan (bantuan)
  81. ↑ "Topical benzoyl peroxide for acne". The Cochrane Database of Systematic Reviews. 3: CD011154. March 2020. doi:10.1002/14651858.CD011154.pub2. PMC 7077870 Periksa nilai |pmc= (bantuan). PMID 32175593.Selenggaraan CS1: display-pengarang (link)
  82. 1 2 "Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris". Expert Opinion on Pharmacotherapy (Review). 10 (15): 2555–62. October 2009. doi:10.1517/14656560903277228. PMID 19761357.
  83. ↑ "Topical dose justification: benzoyl peroxide concentrations". The Journal of Dermatological Treatment (Review). 24 (4): 275–7. August 2013. doi:10.3109/09546634.2011.641937. PMID 22103743.
  84. 1 2 "Topical Retinoids: Therapeutic Mechanisms in the Treatment of Photodamaged Skin". American Journal of Clinical Dermatology (Review). 17 (3): 265–76. June 2016. doi:10.1007/s40257-016-0185-5. PMID 26969582.
  85. ↑ "Drug Trials Snapshots: Aklief". U.S. Food and Drug Administration (FDA). 11 October 2019. Diarkib daripada yang asal pada 19 November 2019. Dicapai pada 18 November 2019. Rencana ini mengandungi teks dari sumber yang berada dalam domain awam.
  86. ↑ "Contact dermatitis to topical acne drugs: a review of the literature". Dermatologic Therapy (Review). 28 (5): 323–9. September 2015. doi:10.1111/dth.12282. PMID 26302055.
  87. ↑ "Oral isotretinoin for acne". The Cochrane Database of Systematic Reviews. 11: CD009435. November 2018. doi:10.1002/14651858.cd009435.pub2. PMC 6383843. PMID 30484286.
  88. 1 2 Tan J, Boyal S, Desai K, Knezevic S (April 2016). "Oral Isotretinoin: New Developments Relevant to Clinical Practice". Dermatologic Clinics (Review). 34 (2): 175–84. doi:10.1016/j.det.2015.11.002. PMID 27015777.
  89. ↑ "Isotretinoin: update on controversial issues". Journal of Pediatric and Adolescent Gynecology (Review). 26 (5): 290–3. October 2013. doi:10.1016/j.jpag.2013.05.007. PMID 24147278.
  90. 1 2 3 "Systematic review of antibiotic resistance in acne: an increasing topical and oral threat" (PDF). The Lancet. Infectious Diseases (Systematic Review). 16 (3): e23-33. March 2016. doi:10.1016/S1473-3099(15)00527-7. PMID 26852728. Diarkib daripada yang asal (PDF) pada 5 November 2018. Dicapai pada 1 January 2019.
  91. 1 2 3 4 5 6 "Approaches to limit systemic antibiotic use in acne: Systemic alternatives, emerging topical therapies, dietary modification, and laser and light-based treatments". Journal of the American Academy of Dermatology (Review). 80 (2): 538–549. February 2019. doi:10.1016/j.jaad.2018.09.055. PMC 6333507. PMID 30296534.
  92. ↑ Hilton, Lisette (2019-03-21). "Dermatologists relying less on antibiotics for acne". Dermatology Times (dalam bahasa Inggeris). Dicapai pada 2020-06-07.
  93. ↑ "Minocycline for acne vulgaris: efficacy and safety". The Cochrane Database of Systematic Reviews (8): CD002086. August 2012. doi:10.1002/14651858.CD002086.pub2. PMC 7017847 Periksa nilai |pmc= (bantuan). PMID 22895927. Diarkib daripada yang asal pada 23 June 2018. Dicapai pada 23 June 2018.
  94. ↑ "Prescribing Information for Seysara" (PDF). Petikan journal memerlukan |journal= (bantuan)
  95. ↑ "Efficacy and Safety of Sarecycline, a Novel, Once-Daily, Narrow Spectrum Antibiotic for the Treatment of Moderate to Severe Facial Acne Vulgaris: Results of a Phase 2, Dose-Ranging Study". Journal of Drugs in Dermatology. 17 (3): 333–338. March 2018. PMID 29537451.
  96. ↑ "Sarecycline: a narrow spectrum tetracycline for the treatment of moderate-to-severe acne vulgaris". Future Microbiology. 14 (14): 1235–1242. September 2019. doi:10.2217/fmb-2019-0199. PMC 6802708. PMID 31475868.
  97. ↑ "Sarecycline". PubChem. U.S. National Library of Medicine. Dicapai pada 2020-06-07.
  98. ↑ "Microbiological Profile of Sarecycline, a Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris". Antimicrobial Agents and Chemotherapy. 63 (1). January 2019. doi:10.1128/AAC.01297-18. PMC 6325184. PMID 30397052.
  99. ↑ "Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical Trials". Journal of Drugs in Dermatology. 17 (9): 987–996. September 2018. PMID 30235387.Selenggaraan CS1: display-pengarang (link)
  100. ↑ "Combined oral contraceptive pills for treatment of acne". The Cochrane Database of Systematic Reviews (Systematic Review & Meta-Analysis). 7 (7): CD004425. July 2012. doi:10.1002/14651858.CD004425.pub6. PMID 22786490.
  101. 1 2 Kuhl H (1999). "Hormonal Contraception". Estrogens and Antiestrogens II. Handbook of Experimental Pharmacology. 135 / 2. halaman 363–407. doi:10.1007/978-3-642-60107-1_18. ISBN 978-3-642-64261-6. ISSN 0171-2004.
  102. 1 2 "Acne in the adult female patient: a practical approach". International Journal of Dermatology. 51 (10): 1162–74. October 2012. doi:10.1111/j.1365-4632.2012.05519.x. PMID 22994662.
  103. ↑ "Pharmacology of estrogens and progestogens: influence of different routes of administration" (PDF). Climacteric. 8 Suppl 1: 3–63. August 2005. doi:10.1080/13697130500148875. PMID 16112947. Diarkib daripada yang asal (PDF) pada 22 August 2016. Dicapai pada 21 December 2018.
  104. ↑ "Estrogens and selective estrogen receptor modulators in acromegaly". Endocrine. 54 (2): 306–314. November 2016. doi:10.1007/s12020-016-1118-z. PMID 27704479.
  105. ↑ "Metabolische Effekte der Östrogene und Gestagene" [Metabolic effects of estrogens and progestogens]. Der Gynäkologe (dalam bahasa Jerman). 30 (4): 357–369. 1997. doi:10.1007/PL00003042. ISSN 0017-5994.
  106. ↑ "Managing cutaneous manifestations of hyperandrogenic disorders: the role of oral contraceptives". Treatments in Endocrinology. 1 (6): 372–86. 2002. doi:10.2165/00024677-200201060-00003. PMID 15832490.
  107. ↑ "Combined oral contraceptive pills for treatment of acne". The Cochrane Database of Systematic Reviews (7): CD004425. July 2012. doi:10.1002/14651858.CD004425.pub6. PMID 22786490.
  108. ↑ "Choosing the Right Oral Contraceptive Pill for Teens". Pediatric Clinics of North America (Review). 64 (2): 343–358. April 2017. doi:10.1016/j.pcl.2016.11.005. PMID 28292450.
  109. ↑ "Use of oral contraceptives for management of acne vulgaris and hirsutism in women of reproductive and late reproductive age". Przeglad Menopauzalny = Menopause Review. 17 (1): 1–4. March 2018. doi:10.5114/pm.2018.74895. PMC 5925193. PMID 29725277.
  110. 1 2 "Meta-analysis comparing efficacy of antibiotics versus oral contraceptives in acne vulgaris". Journal of the American Academy of Dermatology (Systematic Review & Meta-Analysis). 71 (3): 450–9. September 2014. doi:10.1016/j.jaad.2014.03.051. PMID 24880665.
  111. 1 2 Layton AM, Eady EA, Whitehouse H, Del Rosso JQ, Fedorowicz Z, van Zuuren EJ (April 2017). "Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review". American Journal of Clinical Dermatology. 18 (2): 169–191. doi:10.1007/s40257-016-0245-x. PMC 5360829. PMID 28155090.
  112. 1 2 "Is hormonal treatment still an option in acne today?". The British Journal of Dermatology. 172 Suppl 1: 37–46. July 2015. doi:10.1111/bjd.13681. PMID 25627824.
  113. ↑ "How actual is the treatment with antiandrogen alone in patients with polycystic ovary syndrome?". Journal of Endocrinological Investigation. 21 (9): 623–9. October 1998. doi:10.1007/BF03350788. PMID 9856417.
  114. ↑ "Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders". Drugs. 28 (1): 6–37. July 1984. doi:10.2165/00003495-198428010-00002. PMID 6235105.
  115. ↑ Rasmusson, Gary H. (1986). Chemical Control of Androgen Action. Annual Reports in Medicinal Chemistry. 21. halaman 179–188. doi:10.1016/S0065-7743(08)61128-8. ISBN 9780120405213. ISSN 0065-7743.
  116. ↑ "Potential side effects of androgen deprivation treatment in sex offenders". The Journal of the American Academy of Psychiatry and the Law. 37 (1): 53–8. 2009. PMID 19297634.
  117. 1 2 "Androgens in women: Hormone-modulating therapies for skin disease". Journal of the American Academy of Dermatology. 80 (6): 1509–1521. June 2019. doi:10.1016/j.jaad.2018.08.061. PMID 30312645.
  118. ↑ "Adverse effects of acne medications: recognition and management". American Journal of Clinical Dermatology. 16 (4): 231–242. August 2015. doi:10.1007/s40257-015-0127-7. PMID 25896771.
  119. ↑ "FDA. Prescribing Information" (PDF).
  120. ↑ "Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies". Breast Cancer Res. Treat. 174 (1): 15–26. February 2019. doi:10.1007/s10549-018-4996-3. PMC 6773272. PMID 30467659.
  121. ↑ "Oily Skin: A review of Treatment Options". J Clin Aesthet Dermatol. 10 (8): 49–55. August 2017. PMC 5605215. PMID 28979664.
  122. ↑ "Spironolactone and breast cancer: Fear not!". J. Am. Acad. Dermatol. July 2020. doi:10.1016/j.jaad.2020.07.104. PMID 32738426.
  123. ↑ Senofonte, Giulia; Pallotti, Francesco; Lombardo, Francesco (2020). "Ciproterone acetato e meningiomi: lo stato dell'arte" [Cyproterone acetate and meningiomas: the state of the art]. L'Endocrinologo. 21 (3): 171–175. doi:10.1007/s40619-020-00746-8. ISSN 1590-170X.
  124. ↑ "Council of Europe resolution to promote pharmaceutical care in Europe". Eur J Hosp Pharm. 27 (3): 184–188. May 2020. doi:10.1136/ejhpharm-2020-002305. PMC 7223358 Periksa nilai |pmc= (bantuan). PMID 32419942.
  125. ↑ "Female gender and exogenous progesterone exposition as risk factors for spheno-orbital meningiomas". J. Neurooncol. July 2020. doi:10.1007/s11060-020-03576-8. PMID 32705456.
  126. ↑ "Management of acne vulgaris with hormonal therapies in adult female patients". Dermatologic Therapy. 28 (3): 166–72. 2015. doi:10.1111/dth.12231. PMID 25845307.
  127. ↑ "Endocrine disorders and hormonal therapy for adolescent acne". Current Opinion in Pediatrics. 29 (4): 455–465. August 2017. doi:10.1097/MOP.0000000000000515. PMID 28562419.
  128. ↑ "Current aspects of antiandrogen therapy in women". Current Pharmaceutical Design. 5 (9): 707–23. September 1999. PMID 10495361. Diarkib daripada yang asal pada 27 February 2020. Dicapai pada 21 December 2018.
  129. ↑ Shelley, Walter Brown; Shelley, E. Dorinda (2001). Advanced Dermatologic Therapy II. W. B. Saunders. ISBN 978-0-7216-8258-7.
  130. ↑ Balen, Adam; Franks, Stephen; Homburg, Roy; Kehoe, Sean (October 2010). Current Management of Polycystic Ovary Syndrome. Cambridge University Press. halaman 132–. ISBN 978-1-906985-41-7.
  131. ↑ "A Review of hormone-based therapies to treat adult acne vulgaris in women". International Journal of Women's Dermatology. 3 (1): 44–52. March 2017. doi:10.1016/j.ijwd.2017.02.018. PMC 5419026. PMID 28492054.
  132. ↑ "Flutamide-induced hepatotoxicity: ethical and scientific issues". European Review for Medical and Pharmacological Sciences. 21 (1 Suppl): 69–77. March 2017. PMID 28379593.
  133. ↑ Yasa, Cenk; Dural, Özlem; Bastu, Ercan; Uğurlucan, Funda Güngör (2016). "Hirsutism, Acne, and Hair Loss: Management of Hyperandrogenic Cutaneous Manifestations of Polycystic Ovary Syndrome". Gynecology Obstetrics & Reproductive Medicine: 1. doi:10.21613/GORM.2016.613. ISSN 1300-4751.
  134. ↑ "Hormonal therapies for acne". Clinics in Dermatology. 35 (2): 168–172. 2017. doi:10.1016/j.clindermatol.2016.10.009. PMID 28274354.
  135. ↑ "Clinical progress with a new antiandrogen, Casodex (bicalutamide)". European Urology. 29 Suppl 2 (2): 96–104. 1996. doi:10.1159/000473847. PMID 8717470.
  136. ↑ "Bicalutamide (Casodex) in the treatment of prostate cancer". Expert Review of Anticancer Therapy. 4 (1): 37–48. February 2004. doi:10.1586/14737140.4.1.37. PMID 14748655.
  137. ↑ "The use of hormonal agents in the treatment of acne". Seminars in Cutaneous Medicine and Surgery. 35 (2): 68–73. June 2016. doi:10.12788/j.sder.2016.027. PMID 27416311.
  138. ↑ "New Concepts, Concerns, and Creations in Acne". Dermatologic Clinics (Review). 37 (1): 1–9. January 2019. doi:10.1016/j.det.2018.07.002. PMID 30466681.
  139. ↑ Timmins, Peter (2018). "Industry update: the latest developments in the field of therapeutic delivery, July 2018". Therapeutic Delivery (Review). 9 (11): 797–809. doi:10.4155/tde-2018-0055.
  140. ↑ "Emerging Therapies for Acne Vulgaris". American Journal of Clinical Dermatology (Review). 19 (4): 505–516. August 2018. doi:10.1007/s40257-018-0345-x. PMID 29594974.
  141. ↑ "A review of diagnosis and treatment of acne in adult female patients". International Journal of Women's Dermatology (Review). 4 (2): 56–71. June 2018. doi:10.1016/j.ijwd.2017.10.006. PMC 5986265. PMID 29872679.
  142. ↑ "Emerging drugs for the treatment of acne". Expert Opinion on Emerging Drugs. 20 (1): 91–101. March 2015. doi:10.1517/14728214.2015.990373. PMID 25474485.
  143. ↑ "Role of 5α-reductase inhibitors in androgen-stimulated skin disorders". Journal of Drugs in Dermatology. 12 (2): e30-5. February 2013. PMID 23377402.
  144. ↑ Danby, F. William (27 January 2015). Acne: Causes and Practical Management. John Wiley & Sons. halaman 147–. ISBN 978-1-118-23277-4.
  145. ↑ "Clinical biochemistry of dihydrotestosterone". Annals of Clinical Biochemistry. 50 (Pt 2): 95–107. March 2013. doi:10.1258/acb.2012.012159. PMID 23431485.
  146. 1 2 "Hormonal therapy for acne: why not as first line therapy? facts and controversies". Clinics in Dermatology. 28 (1): 17–23. 2010. doi:10.1016/j.clindermatol.2009.03.006. PMID 20082945.
  147. 1 2 "Treatment of acne vulgaris in pregnant patients". Dermatologic Therapy (Review). 26 (4): 302–11. July 2013. doi:10.1111/dth.12077. PMID 23914887.
  148. ↑ "Alternative therapies for common dermatologic disorders, part 2". Primary Care (Review). 37 (2): 285–96. June 2010. doi:10.1016/j.pop.2010.02.005. PMID 20493337.
  149. ↑ "Azelaic Acid Topical". National Institutes of Health. Diarkib daripada yang asal pada 13 September 2013. Dicapai pada 9 September 2013.
  150. ↑ Liu, Haibo; Yu, Haiyan; Xia, Jun; Liu, Ling; Liu, Guan J; Sang, Hong; Peinemann, Frank (2020-05-01). Cochrane Skin Group (penyunting). "Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne". Cochrane Database of Systematic Reviews (dalam bahasa Inggeris). 5: CD011368. doi:10.1002/14651858.CD011368.pub2. PMC 7193765 Periksa nilai |pmc= (bantuan). PMID 32356369.
  151. 1 2 Madan RK, Levitt J (April 2014). "A review of toxicity from topical salicylic acid preparations". Journal of the American Academy of Dermatology (Review). 70 (4): 788–792. doi:10.1016/j.jaad.2013.12.005. PMID 24472429.
  152. ↑ "Acne vulgaris: A review of causes and treatment options". The Nurse Practitioner (Review). 38 (10): 22–31, quiz 32. October 2013. doi:10.1097/01.NPR.0000434089.88606.70. PMID 24048347.
  153. ↑ "A review of nicotinamide: treatment of skin diseases and potential side effects". Journal of Cosmetic Dermatology (Review). 13 (4): 324–8. December 2014. doi:10.1111/jocd.12119. PMID 25399625.
  154. ↑ "The clinical effects of zinc as a topical or oral agent on the clinical response and pathophysiologic mechanisms of acne: a systematic review of the literature". Journal of Drugs in Dermatology (Review). 12 (5): 542–5. May 2013. PMID 23652948.
  155. ↑ "Top Ten List of Clinical Pearls in the Treatment of Acne Vulgaris". Dermatologic Clinics (Review). 34 (2): 147–57. April 2016. doi:10.1016/j.det.2015.11.008. PMID 27015774.
  156. 1 2 3 Tyler KH (March 2015). "Dermatologic therapy in pregnancy". Clinical Obstetrics and Gynecology (Review). 58 (1): 112–8. doi:10.1097/GRF.0000000000000089. PMID 25517754. Parameter |s2cid= yang tidak diketahui diendahkan (bantuan)
  157. "FDA Pregnancy Categories". Chemical Hazards Emergency Medical Management. U.S. Department of Health & Human Services.
  158. ↑ "Pregnancy outcomes following first-trimester exposure to topical retinoids: a systematic review and meta-analysis". The British Journal of Dermatology (Systematic Review & Meta-Analysis). 173 (5): 1132–41. November 2015. doi:10.1111/bjd.14053. PMID 26215715.
  159. ↑ "The management of acne vulgaris in pregnancy". American Journal of Clinical Dermatology (Review). 14 (5): 351–8. October 2013. doi:10.1007/s40257-013-0041-9. PMID 23996075.
  160. ↑ Bolognia JL, Jorizzo JL (2012). Dermatology (ed. 3rd). St. Louis, Mo.: Mosby Elsevier. m/s. 558. ISBN 9780702051821.
  161. ↑ "Light Therapies for Acne". JAMA Dermatology. 154 (5): 597–598. May 2018. doi:10.1001/jamadermatol.2018.0110. PMID 29541753.
  162. ↑ "Laser and other light therapies for the treatment of acne vulgaris: systematic review". The British Journal of Dermatology (Systematic Review & Meta-Analysis). 160 (6): 1273–85. June 2009. doi:10.1111/j.1365-2133.2009.09047.x. PMID 19239470.
  163. ↑ "Light therapies for acne". The Cochrane Database of Systematic Reviews. 9: CD007917. September 2016. doi:10.1002/14651858.CD007917.pub2. PMC 6457763. PMID 27670126. Diarkib daripada yang asal pada 22 June 2018. Dicapai pada 22 June 2018.Selenggaraan CS1: display-pengarang (link)
  164. 1 2 "Microneedling in skin of color: A review of uses and efficacy". Journal of the American Academy of Dermatology (Review). 74 (2): 348–55. February 2016. doi:10.1016/j.jaad.2015.09.024. PMID 26549251.
  165. ↑ "Fractional laser resurfacing for acne scars: a review". The British Journal of Dermatology (Review). 166 (6): 1160–9. June 2012. doi:10.1111/j.1365-2133.2012.10870.x. PMID 22296284.
  166. ↑ "Interventions for acne scars". The Cochrane Database of Systematic Reviews (Systematic Review & Meta-Analysis). 4: CD011946. April 2016. doi:10.1002/14651858.CD011946.pub2. PMC 7069546 Periksa nilai |pmc= (bantuan). PMID 27038134.Selenggaraan CS1: display-pengarang (link)
  167. ↑ "Update on acne scar treatment". Cutis (Review). 102 (1): 21, 25, 47, 48. July 2018. PMID 30138491. Diarkib daripada yang asal pada 19 September 2018. Dicapai pada 19 September 2018.
  168. ↑ ""Tram track effect" after treatment of acne scars using a microneedling device". Dermatologic Surgery (Case Report & Literature Review). 38 (7 Pt 1): 1107–8. July 2012. doi:10.1111/j.1524-4725.2012.02441.x. PMID 22587597.
  169. ↑ "Acne scarring: a review of cosmetic therapies". Cutis (Review). 95 (5): 276–81. May 2015. PMID 26057505.
  170. ↑ "Combination Therapy for Acne Scarring: Personal Experience and Clinical Suggestions". Journal of Drugs in Dermatology (Review). 15 (11): 1413–1419. November 2016. PMID 28095556.
  171. ↑ "Acne Scar Treatment: A Multimodality Approach Tailored to Scar Type". Dermatologic Surgery (Review). 42 Suppl 2 (Supplement 2): S139-49. May 2016. doi:10.1097/DSS.0000000000000746. PMID 27128240.
  172. ↑ "Complementary therapies for acne vulgaris". The Cochrane Database of Systematic Reviews (Systematic Review & Meta-Analysis). 1: CD009436. January 2015. doi:10.1002/14651858.CD009436.pub2. PMC 4486007. PMID 25597924.
  173. ↑ "Botanical and phytochemical therapy of acne: a systematic review". Phytotherapy Research (Systematic Review). 28 (8): 1137–52. August 2014. doi:10.1002/ptr.5125. PMID 25098271.
  174. ↑ "Over-the-counter Acne Treatments: A Review". The Journal of Clinical and Aesthetic Dermatology (Review). 5 (5): 32–40. May 2012. PMC 3366450. PMID 22808307.
  175. 1 2 Goodman G (2009). "Cleansing and moisturizing in acne patients". American Journal of Clinical Dermatology (Review). 10 Suppl 1 (Suppl 1): 1–6. doi:10.2165/0128071-200910001-00001. PMID 19209947. Parameter |s2cid= yang tidak diketahui diendahkan (bantuan)
  176. ↑ Bajaj, Lalit; Berman, Stephen (2011). Berman's Pediatric Decision Making (dalam bahasa Inggeris). Elsevier Health Sciences. m/s. 572. ISBN 978-0323054058. Diarkib daripada yang asal pada 6 September 2017.
  177. ↑ Bope ET, Kellerman RD (2014). Conn's Current Therapy 2015: Expert Consult — Online. m/s. 299. ISBN 978-0-323-31956-0. Diarkib daripada yang asal pada 6 September 2017.
  178. ↑ Andrews, George E; Berger, Timothy G; Elston, Dirk M; James, William D (2011). Andrews' Diseases of the skin : clinical dermatology (ed. 11th). [London]: Saunders/ Elsevier. m/s. 234. ISBN 9781437703146.
  179. ↑ "Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010". Lancet. 380 (9859): 2163–96. December 2012. doi:10.1016/S0140-6736(12)61729-2. PMC 6350784. PMID 23245607.
  180. ↑ "Postadolescent acne in females". Skin Pharmacology and Physiology (Review). 27 Suppl 1 (Supplement 1): 3–8. November 2013. doi:10.1159/000354887. PMID 24280643.
  181. ↑ "Acne in skin of color: practical approaches to treatment". The Journal of Dermatological Treatment (Review). 21 (3): 206–11. May 2010. doi:10.3109/09546630903401496. PMID 20132053.
  182. ↑ "A global perspective on the epidemiology of acne". The British Journal of Dermatology (Review). 172 Suppl 1 (Supplement 1): 3–12. July 2015. doi:10.1111/bjd.13462. PMID 25597339.
  183. ↑ "Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris". Journal of the American Academy of Dermatology (Review). 39 (2 Pt 3): S34-7. August 1998. doi:10.1016/S0190-9622(98)70442-6. PMID 9703121.
  184. ↑ "An update on the management of acne vulgaris". Clinical, Cosmetic and Investigational Dermatology (Review). 2: 105–10. June 2009. doi:10.2147/ccid.s3630. PMC 3047935. PMID 21436973.
  185. 1 2 3 4 5 "Acne pathogenesis: history of concepts". Dermatology (Review). 229 (1): 1–46. September 2014. doi:10.1159/000364860. PMID 25228295.
  186. ↑ Bolognia JL, Jorizzo JL (2012). Dermatology (ed. 3rd). St. Louis, Mo.: Mosby Elsevier. m/s. 545. ISBN 9780702051821.
  187. 1 2 3 Brumberg, Joan Jacobs (9 June 2010). "Perfect Skin". The Body Project: An Intimate History of American Girls (dalam bahasa Inggeris). Knopf Doubleday Publishing Group. halaman 57–94. ISBN 9780307755742. Diarkib daripada yang asal pada 12 March 2017.
  188. ↑ Bulkley, Lucius Duncan (1885). Acne; Its Etiology, Pathology and Treatment (dalam bahasa Inggeris). New York: G.P. Putnam's Sons. Diarkib daripada yang asal pada 5 May 2016. Dicapai pada 15 February 2020.
  189. ↑ "Benzoyl peroxide: enhancing antibiotic efficacy in acne management". Skin Therapy Letter (Review). 15 (10): 5–7. November–December 2010. PMID 21076800. Diarkib daripada yang asal pada 27 February 2017.
  190. ↑ "Tretinoin (retinoic acid) in acne". The Medical Letter on Drugs and Therapeutics. 15 (1): 3. January 1973. PMID 4265099.
  191. ↑ "13-cis retinoic acid and acne". Lancet. 2 (8203): 1048–9. November 1980. doi:10.1016/S0140-6736(80)92273-4. PMID 6107678.
  192. ↑ "Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective". British Journal of Clinical Pharmacology. 63 (2): 196–205. February 2007. doi:10.1111/j.1365-2125.2006.02837.x. PMC 1859978. PMID 17214828.
  193. ↑ "The prescription of isotretinoin to women: is every precaution taken?". The British Journal of Dermatology. 138 (3): 450–5. March 1998. doi:10.1046/j.1365-2133.1998.02123.x. PMID 9580798.
  194. ↑ "No soap and dry ice or a treatment for acne". Canadian Family Physician. 14 (5): 21–2. May 1968. PMC 2281078. PMID 20468218.
  195. ↑ "The X-Ray Treatment of Acne Vulgaris". British Medical Journal (Review). 1 (3099): 700–2. May 1920. doi:10.1136/bmj.1.3099.700. PMC 2337520. PMID 20769902.
  196. ↑ "Acne Vulgaris and X-Ray Treatment". New England Journal of Medicine. 219 (24): 971. December 1938. doi:10.1056/NEJM193812152192414.
  197. ↑ "Sales of the leading acne brands in the United States in 2015 (in million U.S. dollars)". statista: The Statistics Portal. Statista Inc. Diarkib daripada yang asal pada 12 March 2017. Dicapai pada 12 March 2017.
  198. ↑ "Acne--natural history, facts and myths" (PDF). Australian Family Physician (Review). 35 (8): 613–6. August 2006. PMID 16894437. Diarkib daripada yang asal (PDF) pada 11 February 2015.
  199. ↑ "Quality of life in pediatric dermatology". Dermatologic Clinics (Review). 31 (2): 211–21. April 2013. doi:10.1016/j.det.2012.12.010. PMID 23557650.
  200. ↑ "Genome sequence and analysis of a Propionibacterium acnes bacteriophage". Journal of Bacteriology. 189 (11): 4161–7. June 2007. doi:10.1128/JB.00106-07. PMC 1913406. PMID 17400737.Selenggaraan CS1: display-pengarang (link)
  201. ↑ "Probiotics and prebiotics in dermatology". Journal of the American Academy of Dermatology (Review). 71 (4): 814–21. October 2014. doi:10.1016/j.jaad.2014.04.050. PMID 24906613.
  202. ↑ "Propionibacterium acnes in the pathogenesis and immunotherapy of acne vulgaris". Current Drug Metabolism (Review). 16 (4): 245–54. 2015. doi:10.2174/1389200216666150812124801. PMID 26264195.
  203. ↑ "In development: a vaccine for acne". New Scientist. Diarkib daripada yang asal pada 2 April 2015. Dicapai pada 30 March 2015.
  204. ↑ White, Stephen D.; Bordeau, Patrick B.; Blumstein, Philippe; Ibisch, Catherine; GuaguÈre, Eric; Denerolle, Philippe; Carlotti, Didier N.; Scott, Katherine V. (1 September 1997). "Feline acne and results of treatment with mupirocin in an open clinical trial: 25 cases (1994–96)". Veterinary Dermatology (dalam bahasa Inggeris). 8 (3): 157–164. doi:10.1046/j.1365-3164.1997.d01-16.x. ISSN 1365-3164.
  205. ↑ Veterinary Medicine (dalam bahasa Inggeris). 1914. Diarkib daripada yang asal pada 12 March 2017.
  206. ↑ Radostits, Otto M.; Gay, Clive C.; Hinchcliff, Kenneth W.; Constable, Peter D. (28 December 2006). Veterinary Medicine: A textbook of the diseases of cattle, horses, sheep, pigs and goats (dalam bahasa Inggeris). Elsevier Health Sciences. ISBN 9780702039911. Diarkib daripada yang asal pada 12 March 2017.
  207. ↑ White, David Stuart (1917). A Text-book of the Principles and Practice of Veterinary Medicine (dalam bahasa Inggeris). Lea & Febiger. m/s. 258.